ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF Pharmaceutical Investing
Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Pharmaceutical Investing
Sanofi: Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Bioverativ Pharmaceutical Investing
New Published Study Reports Cardiosphere-Derived Cells Improved Skeletal and Cardiac Muscle Function in Mouse Model Biotech Investing
Dermira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Biotech Investing
Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy Biotech Investing
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006 Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness